Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Fineotex Chemical Limited (FCL.NS)
Mumbai, IN
Founded in 1979 and based in Mumbai, India, Fineotex Chemical Limited is a global manufacturer and distributor of a broad spectrum of specialty and auxiliary chemicals. The company develops tailored chemical solutions for the textile industry, covering every stage from pretreatment and dyeing to printing and finishing. Beyond textiles, their extensive product range includes water treatment chemicals, paper adhesives, and defoamers. They also provide essential chemicals such as benzalkonium chloride (BKC), barite, hematite, magnesium chloride, and calcium chloride. Fineotex offers a complete line of drilling fluid chemicals, with both water-based (e.g., clay/shale inhibitors, lubricants, spotting fluids, loss circulation additives) and oil-based formulations. Furthermore, their offerings extend to cleaning and hygiene products, comprising liquid detergents, various disinfectants for hands and surfaces, sanitizing tablets, hand sanitizers, multi-surface cleaners, air fresheners, white phenyl, and detergent cakes. These diverse chemical compounds find critical applications across numerous sectors, including textiles, home care, hygiene, mining, garment manufacturing, water treatment, leather, construction, paints, agrochemicals, and adhesives.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +8.85% | +23.04% | +43.13% | +32.99% | +37.10% | +34.71% | +25.08% | +30.33% | +316.29% | +992.76% | +1,250.41% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-04 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+44.8% ★ Q1'26: +161.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-88.6% Q1'26: -78.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-7.6% Q1'26: +2.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+15.7% ★ Q1'26: +12.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+11.3% ★ Q1'26: +16.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+778.7% Q1'26: +633.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.06× ★ Q1'26: 0.05× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.02B
est: 643.41M (+58.5%)
|
1.09B
est: 721.41M (+50.7%)
|
1.28B
est: 1.20B (+6.6%)
|
1.40B
est: 1.44B (-2.6%)
|
1.81B
est: 1.69B (+7.3%)
|
1.95B
est: 1.93B (+0.9%)
|
2.17B
est: 2.07B (+5.1%)
|
3.67B
est: 2.66B (+37.7%)
|
5.17B
est: 3.37B (+53.6%)
|
5.69B
est: 5.89B (-3.3%)
|
5.33B
est: 5.90B (-9.5%)
|
5.67B
5.67B – 5.67B
-3.9% YoY
|
6.80B
6.80B – 6.80B
+20.1% YoY
|
8.18B
8.18B – 8.18B
+20.3% YoY
|
| EBITDA |
215.21M
est: 163.34M (+31.8%)
|
300.36M
est: 183.14M (+64.0%)
|
298.84M
est: 305.03M (-2.0%)
|
351.40M
est: 364.89M (-3.7%)
|
350.06M
est: 428.16M (-18.2%)
|
232.62M
est: 490.24M (-52.5%)
|
580.62M
est: 524.49M (+10.7%)
|
767.24M
est: 676.30M (+13.4%)
|
1.13B
est: 854.26M (+32.4%)
|
1.65B
est: 1.98B (-16.9%)
|
1.52B
est: 1.99B (-23.8%)
|
1.91B
1.91B – 1.91B
-3.9% YoY
|
2.29B
2.29B – 2.29B
+20.1% YoY
|
2.76B
2.76B – 2.76B
+20.3% YoY
|
| EBIT |
203.19M
est: 156.93M (+29.5%)
|
294.03M
est: 175.96M (+67.1%)
|
383.90M
est: 293.06M (+31.0%)
|
344.88M
est: 350.58M (-1.6%)
|
340.04M
est: 411.36M (-17.3%)
|
220.93M
est: 471.01M (-53.1%)
|
565.88M
est: 503.92M (+12.3%)
|
742.11M
est: 649.78M (+14.2%)
|
1.09B
est: 820.76M (+32.6%)
|
1.59B
est: 1.82B (-12.6%)
|
1.42B
est: 1.82B (-21.9%)
|
1.75B
1.75B – 1.75B
-3.9% YoY
|
2.10B
2.10B – 2.10B
+20.1% YoY
|
2.53B
2.53B – 2.53B
+20.3% YoY
|
| Net Income |
129.15M
est: 52.23M (+147.3%)
|
170.40M
est: 13.06M (+1,205.0%)
|
206.35M
est: 19.42M (+962.8%)
|
226.96M
est: 30.66M (+640.3%)
|
225.24M
est: 26.23M (+758.8%)
|
130.76M
est: 31.22M (+318.8%)
|
425.88M
est: 45.42M (+837.7%)
|
551.74M
est: 40.88M (+1,249.8%)
|
883.16M
est: 54.50M (+1,520.4%)
|
1.20B
est: 123.76M (+868.0%)
|
1.08B
est: 1.13B (-4.0%)
|
897.95M
897.95M – 897.95M
-20.4% YoY
|
1.10B
1.10B – 1.10B
+22.2% YoY
|
1.40B
1.40B – 1.40B
+27.3% YoY
|
| SGA |
44.43M
est: 27.51M (+61.5%)
|
60.66M
est: 30.84M (+96.7%)
|
69.80M
est: 51.37M (+35.9%)
|
38.23M
est: 61.45M (-37.8%)
|
46.57M
est: 72.10M (-35.4%)
|
113.65M
est: 82.56M (+37.7%)
|
102.28M
est: 88.33M (+15.8%)
|
194.03M
est: 113.89M (+70.4%)
|
124.53M
est: 143.86M (-13.4%)
|
250.78M
est: 251.59M (-0.3%)
|
243.18M
est: 252.02M (-3.5%)
|
242.19M
242.19M – 242.19M
-3.9% YoY
|
290.75M
290.75M – 290.75M
+20.1% YoY
|
349.79M
349.79M – 349.79M
+20.3% YoY
|
| EPS |
1.15
est: 0.46 (+150.0%)
|
1.52
est: 0.12 (+1,221.7%)
|
2.32
est: 0.17 (+1,256.7%)
|
2.04
est: 0.27 (+655.6%)
|
2.02
est: 0.23 (+774.5%)
|
1.17
est: 0.28 (+325.5%)
|
3.84
est: 0.40 (+860.0%)
|
4.98
est: 0.36 (+1,283.3%)
|
7.97
est: 0.48 (+1,560.4%)
|
10.82
est: 1.09 (+892.7%)
|
9.53
est: 1.13 (+743.4%)
|
0.90
0.90 – 0.90
-20.4% YoY
|
1.10
1.10 – 1.10
+22.2% YoY
|
1.40
1.40 – 1.40
+27.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | A- | 4/5 | 3/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sanjay Surendra Tibrewala | Chief Financial Officer & Executive Director | 12M | male |
| Surendrakumar Deviprasad Tibrewala | Founder, Non Independent Executive Chairman & MD | 12M | male |
| Aarti Mitesh Jhunjhunwala | Executive Director | 9M | female |
| S. R. Iyer (English Literature) | National Head of Marketing | — | male |
| Hitesh Bhadra | Vice President of Finance & Accounts | — | male |
| Sunny Bharatbhai Parmar | Company Secretary & Compliance Officer | — | male |
| Arindam Choudhuri | Chief Executive Officer | — | male |
| Suresh Desai | Technical Head | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FCL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
